Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “adeno-associated”

69 pharma patents match "adeno-associated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 69
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 69 pharmaceutical patents matching "adeno-associated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

69 results for “adeno-associated” · 30,257 patents in full index Clear search

  1. US 12257277

    Adeno-associated virus formulations

    Takeda Pharmaceutical Company Limited · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  2. US 12246047

    Adeno-associated virus purification methods

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  3. US 12239692

    Adeno-associated virus factor VIII vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  4. US 12188039

    Recombinant adeno-associated viral vector for gene delivery

    The Board of Regents of the University of Texas System · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  5. US 12121567

    Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase

    Regents of the University of Minnesota · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  6. US 12104165

    Adeno-associated virus with engineered capsid

    Tenaya Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  7. US 12104163

    Adeno-associated virus vectors for treatment of Rett syndrome

    Sarepta Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  8. US 12070510

    Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid

    REGENXBIO INC. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  9. US 12031147

    Adeno-associated virus virions with variant capsids and methods of use thereof

    The Regents of the University of California · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  10. US 11925675

    Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  11. US 11840704

    Adeno-associated virus variant capsids and methods of use thereof

    4D MOLECULAR THERAPEUTICS INC. · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  12. US 11821008

    Liver targeting adeno-associated viral vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  13. US 11807868

    Adeno-associated variants, formulations and methods for pulmonary delivery

    4D MOLECULAR THERAPEUTICS INC. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  14. US 11766489

    Adeno-associated virus variant capsids and use for inhibiting angiogenesis

    4D MOLECULAR THERAPEUTICS INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted
  15. US 11761003

    Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof

    EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITY · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted
  16. US 11690898

    Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  17. US 11680249

    Adeno-associated virus capsid variants and methods of use thereof

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  18. US 11584780

    Adeno-associated virus capsid proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  19. US 11583563

    Adeno-associated virus formulations

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  20. US 11565000

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  21. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  22. US 11554180

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted
  23. US 11535870

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  24. US 11499166

    Adeno-associated variants, formulations and methods for pulmonary delivery

    4D MOLECULAR THERAPEUTICS INC. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted